Medline stock climbs from 52-week low levels

Medline Inc. shares rose nearly 5.0% during morning trading on Tuesday, rebounding from levels close to the stock's 52-week low of $31.49. The company did not release any announcements on the day.

Around 20 Wall Street analysts cover the stock, with most holding Buy-equivalent ratings. The average 12-month price target stands well above current trading levels.

The stock has traded at levels below analyst consensus targets for an extended period.

You May Also Be Interested In

• Boeing wins Japan aircraft support deal worth $159 million
• Curtiss-Wright shares drop on CEO succession plan
• Goldman Sachs on Viking Therapeutic (VKTX): 'we believe these results look encouraging'